Filing Flows › Bio Key International (BKYI) › Q1 2026
Bio Key International (BKYI) Q1 2026 earnings results (first quarter 2026)
10-Q filed Jun 22, 2026
Bio Key International (BKYI) reported revenue of $2.1M for the first quarter 2026 (Q1 2026), +33% from a year earlier and +98% from the quarter before. Operating margin was -7.4%, net loss $205K (9.6% of revenue).
Bio Key International, Q1 2026: revenue $2.1M (+34% year over year), operating margin -7.4%, net loss $205K, operating cash flow −$358K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | +98% | +33% |
| Operating profit | −$158K | — | — |
| Net earnings | −$205K | — | — |
| Operating cash flow | −$358K | — | — |
What changed
Revenue was $2.1M in Q1 2026, up 33% year over year and up 98% from the previous quarter. License was the largest line at 64% of revenue. Hardware added $295K year over year (up 125%), 55% of the total change. Service declined 9%.
Gross margin was 82.5%, down 0.1 points from Q1 2025. Operating costs exceeded revenue by $158K, an operating margin of -7.4%. Operating expenses fell 2% while revenue rose 33%. The quarter ended with a net loss of $205K, narrower than the previous quarter's $4.3M loss.
Operating cash flow was −$358K. Non-cash charges added back $71K of depreciation and amortization and $41K of share-based compensation. Working capital and other items used $264K.
Questions
What was Bio Key International's revenue in the first quarter 2026?
Bio Key International (BKYI) reported revenue of $2.1M for the first quarter 2026 (Q1 2026), +33% from a year earlier and +98% from the quarter before.
Was Bio Key International profitable in the first quarter 2026?
Operating loss was $158K (-7.4% of revenue) and net loss $205K.